FIELD: pharmaceutics.
SUBSTANCE: invention relates to compounds of the formula I, their pharmaceutically acceptable compositions suitable as TLR7/8 antagonists.
EFFECT: obtaining TLR7/8 antagonists.
10 cl, 33 ex, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
QUINOLINE-2 DERIVATIVES AS C-KIT KINASE INHIBITORS | 2016 |
|
RU2754858C2 |
ISOINDOLINE COMPOUND, PRODUCTION METHOD, PHARMACEUTICAL COMPOSITION AND THEIR USE | 2019 |
|
RU2813232C2 |
4-(IMIDAZO[1,2-A]PYRIDIN-3-YL)-PYRIMIDINE DERIVATIVES | 2020 |
|
RU2822388C2 |
BENZIMIDAZOLE DERIVATIVES EFFECTIVE IN TREATING RESPIRATORY SYNCYTIAL VIRUS INFECTION | 2012 |
|
RU2612530C2 |
OXOQUINAZOLINYL-BUTANAMIDE DERIVATIVES | 2014 |
|
RU2669393C2 |
PIPERIDINE UREA DERIVATIVES | 2014 |
|
RU2666894C2 |
CLASS OF BIFUNCTIONAL CHIMERIC HETEROCYCLIC COMPOUNDS FOR TARGETED DESTRUCTION OF ANDROGEN RECEPTORS AND USE THEREOF | 2020 |
|
RU2825000C2 |
3-AMINOCYCLOPENTANCARBOXAMIDE DERIVATIVES | 2013 |
|
RU2641913C2 |
MACROCYCLIC PYRIDAZINONE DERIVATIVES | 2014 |
|
RU2660435C2 |
PYRAZOLE COMPOUNDS, THEIR PHARMACEUTICAL COMPOSITIONS AND THEIR APPLICATION | 2019 |
|
RU2770835C1 |
Authors
Dates
2021-11-01—Published
2017-08-07—Filed